Discovery of adamantane-based α-hydroxycarboxylic acid derivatives as potent M2-S31N blockers of influenza A virus
Bioorganic Chemistry · 2025
DOI: 10.1016/j.bioorg.2025.109124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Jianghong Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China. Electronic address: hndxdjh555@163.com. Hauptthemen laut MEDLINE: Adamantane, Antiviral Agents, Viral Matrix Proteins, Drug Discovery. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Henan Provincial Science and Technology Research Project, Division of Graduate Education.
Abstract (Originalsprache)
The clinical discontinuation of amantadine and rimantadine due to widespread drug resistance highlights the need for new chemical entities that target the M2 ion channel to fight influenza outbreaks and pandemics. Based on the resistance mechanism of adamantane-based drugs and the crystal structure of the S31N mutant, we have designed and synthesized a series of adamantane-based α-hydroxycarboxylic acid derivatives using the molecular hybridization principle and induced fit docking studies. Their biological assays were performed on the wild-type influenza A virus A/HK/68 (H3N2) and adamantane-resistant A/M2-S31N mutant viruses A/WSN/33 (H1N1) were tested in vitro. Among them, the most potent compound 3p showed dual inhibitory activity against both the wild-type and the drug-resistant mutant viruses, with EC50 values of 0.92 μM and 0.55 μM, respectively. Its activity was comparable to that of oseltamivir. Additionally, this compound had a higher selectivity index (SI = 651). Notably, compound 3p, as a proven M2-S31N blocker, strongly bound to the drug-binding sites through hydrophobic interactions, three π-π interactions, two hydrogen bonds, and a cation-π interaction. Furthermore, the ADMET properties were calculated using the QikProp of the Schrödinger suite, which showed desirable pharmacokinetic characteristics for further development. This work expands the chemical space of adamantane-based compounds and opens up a new direction for the development of anti-influenza drugs with diverse structures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China. Electronic address: hndxdjh555@163.com.
- College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China.
- Henan Eye Institute, Henan Eye Hospital, People's Hospital of Zhengzhou University, Henan University School of Medicine, Henan Provincial People's Hospital, Zhengzhou 450003, China. Electronic address: dem-3882608@zzu.e…
Förderung
- Henan Provincial Science and Technology Research Project
- Division of Graduate Education
Zitieren
APA
Dong, J., Chen, C., Sun, X., Pei, Q., Wang, P., Yu, M., & Du, E. (2025). Discovery of adamantane-based α-hydroxycarboxylic acid derivatives as potent M2-S31N blockers of influenza A virus. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.109124
Vancouver
Dong J, Chen C, Sun X, Pei Q, Wang P, Yu M, et al. Discovery of adamantane-based α-hydroxycarboxylic acid derivatives as potent M2-S31N blockers of influenza A virus. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.109124
BibTeX
@article{Dong2025,
author = {Dong, Jianghong and Chen, Changjuan and Sun, Xin and Pei, Qinglan and Wang, Panpan and Yu, Miao and Du, Enming},
title = {Discovery of adamantane-based α-hydroxycarboxylic acid derivatives as potent M2-S31N blockers of influenza A virus},
journal = {Bioorganic Chemistry},
year = {2025},
doi = {10.1016/j.bioorg.2025.109124}
}
EUVIMED